On this paper, we current new knowledge on the genus Macrosaldula Leston Southwood, 1964 primarily based on materials held within the collections of the Nationwide Museum (Prague, Czech Republic) and the Zoological Institute of the Russian Academy of Sciences (St. Petersburg, Russia). Macrosaldula graziae sp. nov., from South Uzbekistan and Tajikistan, is described.
Among the many Central Asian species of the genus, it’s near M. tadzhika (Kiritshenko, 1912) by the presence of lengthy erect setae on the physique dorsum, however the latter species differs within the smaller physique dimension, the presence of sunshine spots on the corium, and within the construction of the male genitalia.
In extraordinarily darkish specimens of M. jakowleffi (Reuter, 1891), the hemelytra are opaque, with brief erect setae. Siberian M. rivularia (J. Sahlberg, 1878), M. simulans Cobben, 1985 and the Far Jap M. koreana (Kiritshenko, 1912) and M. violacea Cobben, 1985 are distinguished from the brand new species by the brief pubescence on the dorsum.
We offer new distributional knowledge for M. clavalis Cobben, 1985 (Georgia), M. jakowleffi (Reuter, 1891) (China: Xinjiang: Altai Mts.-first file), M. miyamotoi Cobben, 1985 (Japan: Honshu), M. nivalis (Lindberg, 1935) (Afghanistan-first file, Kyrgyzstan, Tajikistan), M. scotica (Curtis, 1835) (Georgia: Adzharia; Russia: Murmansk District), and M. tadzhika (Afghanistan-first file, Tajikistan, Uzbekistan). The file of M. scotica from Uzbekistan is disconsidered, and the 2 specimens are referred to M. graziae sp. nov.
Inherited glycosylphosphatidylinositol defects trigger the uncommon Emm-negative blood phenotype and developmental issues
Glycosylphosphatidylinositol (GPI) is a glycolipid that anchors greater than 150 proteins to the cell floor. Pathogenic variants in a number of genes that take part in GPI biosynthesis trigger inherited GPI deficiency (IGD) issues. Right here, we reported that homozygous null alleles of PIGG, a gene concerned in GPI modification, are accountable for the uncommon Emm-negative blood phenotype.
Utilizing a panel of Okay562 cells faulty in each the GPI-transamidase and GPI transforming pathways, we reveal that the Emm antigen, whose molecular foundation has remained unknown for many years, is carried solely by free GPI and that its epitope consists of the second and third ethanolamine of the GPI spine. Importantly, we present that the lower in Emm expression in a number of IGD sufferers is indicative of GPI defects. Total, our findings set up Emm as a novel blood group system and have vital implications for understanding the organic operate of human free GPI.
Environmental Multimedia Modeling System (EMMS) for Well being Danger Evaluation: Key Influencing Elements and Uncertainties Researches
On this paper, a former developed Environmental Multimedia Modeling System (EMMS) combining with threat evaluation Monte Carlo Technique (MCM) was additional used for exploring the interplay between groundwater and floor water. When utilizing this EMMS-MCM simulation, this paper consider combining a number of influencing components on its permeability coefficient and different parameters, reminiscent of hydraulic conductivity, density, recharge, layers, and depth.
These influencing components are key components to the unsure pure geological media and hydrographical components, inflicting huge challenges associated to the optimum allocation of water. Particularly, the system working with an EMMS-MCM simulation mixed with Danger Quotient (RQ) would be the supply of quantitative evaluation and analysis of environmental threat hazards, and the environmental threat hazards are inside the acceptable vary when contemplating optimum water allocation.
The EMMS-MCM is verified and analyzed by evaluating the info of hazardous websites with the investigation outcomes contemplating these influencing components. A case research of benzene emissions from Path Street Landfill Website reveals that the higher and center aquifers circulate within the northwest route. Within the south and close to the west of the Path Street landfill, groundwater flows north. About 60% of the expected focus of benzene falls inside the vary of 1.15E-6 to 2.65E-6 kg/m3 .
RQ threat evaluation for the groundwater signifies that threat stage lower from 2016 to 2026. The usage of EMMS-MCM simulation will assist to make hazardous area checks and future environmental administration as affordable as potential and allow one to foretell the potential penalties of hazardous groundwater contamination after contemplating some water allocation components.
The mixing of the EMMS-MCM and RQ would be the greatest instrument for a quicker and extra correct evaluation of the long-term dangers to pollutant diffusion areas, particularly floor and groundwater environmental administration.
A potential survey of Streptococcus pyogenes infections in French Brittany from 2009 to 2017: Complete dynamic of latest emergent emm genotypes
Streptococcus pyogenes or group A Streptococcus (GAS) causes illnesses starting from uncomplicated pharyngitis to life-threatening infections. It has complicated epidemiology pushed by the variety, the temporal and geographical fluctuations of the circulating strains. Regardless of the worldwide burden of GAS illnesses, there may be at the moment no out there vaccination technique in opposition to GAS infections.
This research, primarily based on a longitudinal inhabitants survey, aimed to know the dynamic of GAS emm sorts and to offer results in higher recognition of underlying mechanisms for the emergence of profitable clones. From 2009 to 2017, we performed a scientific culture-based analysis of GAS infections in a French Brittany inhabitants with a potential restoration of medical knowledge.
The epidemiological evaluation was carried out utilizing emm typing mixed with the structural and purposeful cluster-typing system for all of the recovered strains. Danger components for the invasiveness, recognized by univariate evaluation, had been computed in a a number of logistic regression evaluation, and the one unbiased threat issue remaining within the mannequin was the age (OR for the complete vary [CI95%] = 6.35 [3.63, 11.10]; p<0.0001).
Among the many 61 totally different emm sorts recognized, essentially the most prevalent had been emm28 (16%), emm89 (15%), emm1 (14%), and emm4 (8%), which accounted for greater than 50% of circulating strains. In the course of the research interval, 5 genotypes recognized as emm44, 66, 75, 83, 87 emerged successively and belonged to clusters D4, E2, E3, and E6 that had been totally different from these gathering “Prevalent” emm sorts (clusters A-C3 to five, E1 and E4).
Anti-CD147/BSG Antibody |
|||
| PB9247 | BosterBio | 100ug/vial | 334 EUR |
Anti-Hu CD147 Purified |
|||
| 11-274-C025 | ExBio | 0.025 mg | 104 EUR |
Anti-Hu CD147 Purified |
|||
| 11-274-C100 | ExBio | 0.1 mg | 167 EUR |
Anti-Hu CD147 Purified |
|||
| 11-454-C025 | ExBio | 0.025 mg | 104 EUR |
Anti-Hu CD147 Purified |
|||
| 11-454-C100 | ExBio | 0.1 mg | 167 EUR |
Anti-Hu CD147 APC |
|||
| 1A-274-T025 | ExBio | 25 tests | 140 EUR |
Anti-Hu CD147 APC |
|||
| 1A-274-T100 | ExBio | 100 tests | 240 EUR |
Anti-Hu CD147 Biotin |
|||
| 1B-274-C025 | ExBio | 0.025 mg | 122 EUR |
Anti-Hu CD147 Biotin |
|||
| 1B-274-C100 | ExBio | 0.1 mg | 204 EUR |
Anti-Hu CD147 FITC |
|||
| 1F-274-T025 | ExBio | 25 tests | 122 EUR |
Anti-Hu CD147 FITC |
|||
| 1F-274-T100 | ExBio | 100 tests | 204 EUR |
Anti-Hu CD147 PE |
|||
| 1P-274-T025 | ExBio | 25 tests | 140 EUR |
Anti-Hu CD147 PE |
|||
| 1P-274-T100 | ExBio | 100 tests | 240 EUR |
Mouse Monoclonal Anti-Human CD147, Unlabeled |
|||
| CD147UL-100 | Alpha Diagnostics | 100 ug | 408 EUR |
CD147 |
|||
| 147A1-100T | ImmunoStep | 100 test | 349 EUR |
CD147 |
|||
| 147CFB1-100T | ImmunoStep | 100 test | 388 EUR |
CD147 |
|||
| 147F1-100T | ImmunoStep | 100 test | 297 EUR |
CD147 |
|||
| 147P1E-100T | ImmunoStep | 100 test | 349 EUR |
CD147 |
|||
| 147PE2-100T | ImmunoStep | 100 test | 349 EUR |
CD147 |
|||
| 147PP1-100T | ImmunoStep | 100 test | 349 EUR |
CD147 |
|||
| 147PU1-01MG | ImmunoStep | 0,1 mg | 219 EUR |
Anti-CD147 Rabbit Monoclonal Antibody |
|||
| M00248-1 | BosterBio | 100ug/vial | 397 EUR |
|
Description: Rabbit Monoclonal CD147 Antibody. Validated in IF, WB and tested in Human, Mouse, Rat. |
|||
Anti-CD147/Emmprin/BSG Antibody |
|||
| A00248-1 | BosterBio | 100ug/vial | 334 EUR |
Anti-Hu CD147 Alexa Fluor488 |
|||
| A4-274-T025 | ExBio | 25 tests | 154 EUR |
Anti-Hu CD147 Alexa Fluor488 |
|||
| A4-274-T100 | ExBio | 100 tests | 269 EUR |
Anti-CD147 Antibody (BSG/963) |
|||
| A1475-100 | Biovision | 479 EUR | |
Mouse Anti Human Cd147 Monoclonal Antibody,RPE |
|||
| CABT-47077MH | Creative Diagnostics | 100 TEST | 710 EUR |
Mouse Monoclonal Anti-Human CD147-FITC conjugate |
|||
| CD147F-100 | Alpha Diagnostics | 100 Tests | 469 EUR |
Mouse Monoclonal Anti-Human CD147-PE conjugate |
|||
| CD147P-100 | Alpha Diagnostics | 100 Tests | 469 EUR |
Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | 280 EUR |
Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | 280 EUR |
Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | 280 EUR |
CD147 Antibody |
|||
| 49372-100ul | SAB | 100ul | 333 EUR |
CD147 Antibody |
|||
| 49372-50ul | SAB | 50ul | 239 EUR |
CD147 Antibody |
|||
| AF5221 | Affbiotech | 200ul | 304 EUR |
|
Description: CD147 Antibody detects endogenous levels of total CD147. |
|||
CD147 Antibody |
|||
| ABF0428 | Lifescience Market | 100 ug | 438 EUR |
CD147 Antibody |
|||
| ABF5221 | Lifescience Market | 100 ug | 438 EUR |
CD147 Antibody |
|||
| ABD3164 | Lifescience Market | 100 ug | 438 EUR |
CD147 antibody |
|||
| 10R-CD147aHU | Fitzgerald | 100 ug | 404 EUR |
|
Description: Mouse monoclonal CD147 antibody |
|||
CD147 Antibody |
|||
| AF0428 | Affbiotech | 200ul | 304 EUR |
|
Description: CD147 Antibody detects endogenous levels of CD147. |
|||
CD147 antibody |
|||
| 70R-31695 | Fitzgerald | 100 ug | 327 EUR |
|
Description: Rabbit polyclonal CD147 antibody |
|||
CD147 antibody |
|||
| 70R-14065 | Fitzgerald | 100 ug | 322 EUR |
|
Description: Affinity purified Mouse polyclonal CD147 antibody |
|||
CD147 antibody |
|||
| 70R-51470 | Fitzgerald | 100 ul | 244 EUR |
|
Description: Purified Polyclonal CD147 antibody |
|||
Anti-Hu CD147 Purified Low Endotoxin |
|||
| 12-507-C100 | ExBio | 0.1 mg | 167 EUR |
Mouse Anti Rat Cd147 Monoclonal Antibody |
|||
| CABT-47096MR | Creative Diagnostics | 2 ml | 533 EUR |
Mouse Anti Human Cd147 Monoclonal Antibody,AZIDE FREE |
|||
| CABT-47078MH | Creative Diagnostics | 0.1 mg | 663 EUR |
Mouse Monoclonal Anti-Human CD147-PE-Cy5-conjugate |
|||
| CD147PC-100 | Alpha Diagnostics | 100 Tests | 469 EUR |
Human CD147 ELISA Kit |
|||
| EHC0241 | Abclonal | 96Tests | 521 EUR |
CD147 ELISA KIT|Human |
|||
| EF006740 | Lifescience Market | 96 Tests | 689 EUR |
Human CellExp? CD147, human recombinant |
|||
| 7455-10 | Biovision | 245 EUR | |
Human CellExp? CD147, human recombinant |
|||
| 7455-50 | Biovision | 697 EUR | |
Rat Anti Mouse Cd147 Monoclonal Antibody,Biotin |
|||
| CABT-47085RM | Creative Diagnostics | 0.1 mg | 429 EUR |
Rat Anti Mouse Cd147 Monoclonal Antibody,FITC |
|||
| CABT-47088RM | Creative Diagnostics | 0.1 mg | 455 EUR |
Rat Anti Mouse Cd147 Monoclonal Antibody,RPE |
|||
| CABT-47093RM | Creative Diagnostics | 100 TEST | 533 EUR |
Mouse Anti Rat Cd147 Monoclonal Antibody,FITC |
|||
| CABT-47094MR | Creative Diagnostics | 0.1 mg | 543 EUR |
Anti Human CD147 (EMMPRIN) Monoclonal Antibody (Clone No.2G2) |
|||
| KS130 | Sceti | 714 EUR | |
|
Description: The Anti Human CD147 (EMMPRIN) Monoclonal Antibody (Clone No.2G2) is available in Europe and for worldwide shipping via Gentaur. |
|||
Anti-Human CD147/Emmprin DyLight® 488 conjugated Antibody |
|||
| A00248-Dyl488 | BosterBio | 100ug/vial | 344 EUR |
Anti-Human CD147/Emmprin DyLight® 550 conjugated Antibody |
|||
| A00248-Dyl550 | BosterBio | 100ug/vial | 344 EUR |
CD147(CB43) Antibody |
|||
| BNC040363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC040363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC040424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC040424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147 Blocking Peptide |
|||
| 20-abx061356 | Abbexa |
|
|
CD147 Blocking Peptide |
|||
| 20-abx062045 | Abbexa |
|
|
CD147(CB43) Antibody |
|||
| BNC470363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC470363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC470424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC470424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC550363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC550363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCAP0363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCAP0363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCAP0424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCAP0424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCB0363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCB0363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCB0424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCB0424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC810363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC810363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC810424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC810424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Basigin (CD147) Antibody |
|||
| 20-abx133774 | Abbexa |
|
|
CD147 Antibody (FITC) |
|||
| abx133900-100Assays | Abbexa | 100 Assays | 439 EUR |
CD147 Antibody (FITC) |
|||
| abx133900-50Assays | Abbexa | 50 Assays | 342 EUR |
Basigin (CD147) Antibody |
|||
| 20-abx133902 | Abbexa |
|
|
Basigin (CD147) Antibody |
|||
| abx139070-01mg | Abbexa | 0.1 mg | 370 EUR |
CD147 Antibody (Biotin) |
|||
| abx139074-01mg | Abbexa | 0.1 mg | 425 EUR |
Basigin (CD147) Antibody |
|||
| abx139069-01mg | Abbexa | 0.1 mg | 370 EUR |
Basigin (CD147) Antibody |
|||
| abx139071-01mg | Abbexa | 0.1 mg | 370 EUR |
CD147 Antibody (FITC) |
|||
| abx139075-100tests | Abbexa | 100 tests | 425 EUR |
Basigin (CD147) Antibody |
|||
| 20-abx007567 | Abbexa |
|
|
Basigin (CD147) Antibody |
|||
| 20-abx013476 | Abbexa |
|
|
Basigin (CD147) Antibody |
|||
| abx019020-100ug | Abbexa | 100 ug | 342 EUR |
CD147 Antibody (Biotin) |
|||
| abx021360-100ug | Abbexa | 100 ug | 551 EUR |
Basigin (CD147) Antibody |
|||
| abx021361-02mg | Abbexa | 0.2 mg | 1094 EUR |
CD147(CB43) Antibody |
|||
| BNC700363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC700363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC700424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC700424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC880363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC880363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC880424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC880424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC940363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC940363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC940424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC940424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC610424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC610424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC680363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC680363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC680424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC680424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCA0363-250 | Biotium | 250uL | 383 EUR |
|
Description: Primary antibody against CD147(CB43), APC conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCA0424-250 | Biotium | 250uL | 383 EUR |
|
Description: Primary antibody against CD147(8D6), APC conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNUM0363-50 | Biotium | 50uL | 395 EUR |
|
Description: Primary antibody against CD147(CB43), 1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNUM0424-50 | Biotium | 50uL | 395 EUR |
|
Description: Primary antibody against CD147(8D6), 1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCP0363-250 | Biotium | 250uL | 383 EUR |
|
Description: Primary antibody against CD147(CB43), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCP0424-250 | Biotium | 250uL | 383 EUR |
|
Description: Primary antibody against CD147(8D6), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC050363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC050363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC050424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC050424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC400363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC400363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC400424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC400424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCR0363-250 | Biotium | 250uL | 383 EUR |
|
Description: Primary antibody against CD147(CB43), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCR0424-250 | Biotium | 250uL | 383 EUR |
|
Description: Primary antibody against CD147(8D6), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNUB0363-100 | Biotium | 100uL | 209 EUR |
|
Description: Primary antibody against CD147(CB43), Concentration: 0.2mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNUB0363-500 | Biotium | 500uL | 458 EUR |
|
Description: Primary antibody against CD147(CB43), Concentration: 0.2mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNUB0424-100 | Biotium | 100uL | 209 EUR |
|
Description: Primary antibody against CD147(8D6), Concentration: 0.2mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNUB0424-500 | Biotium | 500uL | 458 EUR |
|
Description: Primary antibody against CD147(8D6), Concentration: 0.2mg/mL |
|||
Basigin (CD147) Antibody |
|||
| abx413466-02mg | Abbexa | 0.2 mg | 565 EUR |
Basigin (CD147) Antibody |
|||
| abx413470-1mg | Abbexa | 1 mg | 829 EUR |
Basigin (CD147) Antibody |
|||
| abx413959-025mg | Abbexa | 0.25 mg | 565 EUR |
Basigin (CD147) Antibody |
|||
| abx413960-01mg | Abbexa | 0.1 mg | 439 EUR |
Basigin (CD147) Antibody |
|||
| abx414662-01mg | Abbexa | 0.1 mg | 759 EUR |
Basigin (CD147) Antibody |
|||
| abx415446-2ml | Abbexa | 2 ml | 606 EUR |
Basigin (CD147) Antibody |
|||
| abx200501-100ug | Abbexa | 100 ug | 328 EUR |
CD147 Antibody (FITC) |
|||
| abx200502-100tests | Abbexa | 100 tests | 398 EUR |
Basigin (CD147) Antibody |
|||
| abx231430-100ug | Abbexa | 100 ug | 481 EUR |
CD147(CB43) Antibody |
|||
| BNC430363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC430363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC430424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC430424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCH0363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCH0363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCH0424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCH0424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC550424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC550424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC610363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC610363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC800363-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(CB43), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC800363-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(CB43), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC800424-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CD147(8D6), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC800424-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CD147(8D6), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147 Conjugated Antibody |
|||
| C49372 | SAB | 100ul | 397 EUR |
CD147 Blocking Peptide |
|||
| AF5221-BP | Affbiotech | 1mg | 195 EUR |
CD147 antibody (PE) |
|||
| 61R-1311 | Fitzgerald | 50 ug | 208 EUR |
|
Description: Rat monoclonal CD147 antibody (PE) |
|||
CD147 antibody (biotin) |
|||
| 61R-CD147aHUBT | Fitzgerald | 100 ug | 413 EUR |
|
Description: Mouse monoclonal CD147 antibody (biotin) |
|||
CD147 antibody (PE) |
|||
| 61R-CD147aHUPE | Fitzgerald | 120 tests | 586 EUR |
|
Description: Mouse monoclonal CD147 antibody (PE) |
|||
CD147 Blocking Peptide |
|||
| AF0428-BP | Affbiotech | 1mg | 195 EUR |
Human CD147/EMMPRIN ELISA Kit |
|||
| EHE0043 | Abclonal | 96Tests | 521 EUR |
We beforehand reported vital genetic modifications for emm44, 66, 83 and 75 sorts ensuing probably from a brief adaptive evolution. Herein we moreover noticed that the emergence of a brand new genotype may happen in a prone inhabitants having particular threat components or in all probability missing a naturally-acquired cluster-specific immune cross-protection. Amongst emergent emm sorts, emm75 and emm87 are inclined to grow to be prevalent with a steady annual incidence and the danger of a clonal growth need to be thought of.